参加IAEA关于正电子放射性药品会议后的思考  

Introduction of IAEA Meeting In Bangkok and Thinking on Control of Pet Radiopharmaceuticals

作　　者：钟建国[1] 李彦生[2] 罗志福[3] 

机构地区：[1]中国药品生物制品检定所,北京100050 [2]天津医科大学总医院 [3]中国原子能科学研究院同位素研究所

出　　处：《中国药事》2009年第7期715-717,共3页Chinese Pharmaceutical Affairs

摘　　要：目的为加强我国正电子放射性药品的监督管理提供参考。方法简要介绍了国际原子能机构于2008年3月在泰国曼谷举行的"建立回旋加速器放射性药物生产设施和实施GMP的主题会议"有关情况。结果与结论通过参加这次国际会议,认识到我国医疗机构制备正电子放射性药品管理上的不足,并提出了相关建议以加强正电子放射性药品的管理。Objective It was reference to strengthen the supervision and management of PET radiopharmaceuticals. Methods The article briefly introduced the Thematic Meeting on Establishment of Cyclotron Radiopharmaceutical Production Facility and Implementation of cGMP held by IAEA in Bangkok, Thailand, March, 2008. Results and Conclusions Through attending the meeting, we realized the deficiency for the control of PET radiopharmaceuticals produced by medical institutions in China, and gave some suggestions on how to improve the management of PET radiopharmaceuticals.

关 键 词：IAEA会议 正电子放射性药品 管理 

分 类 号：R95[医药卫生—药学]